Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study

Giulia Stella (Pavia, Italy), Giulia Stella, Emanuela Cova, Simona Inghilleri, Davide Piloni, Miriam Colombo, Simona Mrakic-Sposta, Laura Pandolfi, Angelo Corsico, Ymera Pignochino, Davide Prosperi, Patrizia Morbini, Federica Meloni

Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Session: Emerging technologies for malignant pleural diseases management
Session type: Oral Presentation
Number: 5003
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Giulia Stella (Pavia, Italy), Giulia Stella, Emanuela Cova, Simona Inghilleri, Davide Piloni, Miriam Colombo, Simona Mrakic-Sposta, Laura Pandolfi, Angelo Corsico, Ymera Pignochino, Davide Prosperi, Patrizia Morbini, Federica Meloni. Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study. Eur Respir J 2015; 46: Suppl. 59, 5003

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Intrapleural photodynamic therapy for malignant pleural mesothelioma: A new dosimetry approach
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Volume quantification of malignant pleural mesothelioma
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016

Malignant pleural mesothelioma: A retrospective analysis of 32 cases
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


A conditional mouse model of malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016


Treatment of malignant pleural mesothelioma: dilemmas
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005

Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Effect of asbestos on gene expression of tight junctions components in malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Effects of cisplatin and pemetrexed on 3D phenotypes of benign mesothelial and malignant pleural mesothelioma cells
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Malignant mesothelioma vs metastatic carcinoma of pleura: Do pathology and radiology agree?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013

Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Novel therapeutic strategies against malignant pleural mesothelioma by selumetinib-loaded targeted nanoparticles.
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012